Antimicrobials, Oncology, Antidotes, Adverse Effects & Cytochrome P450 Interactions
Advanced pharmacology covering antibacterial, antifungal, and antiviral mechanisms, cytotoxic and targeted cancer therapies, checkpoint inhibitors, clinical toxicology antidotes, pharmacogenomics, and CYP450 interactions.
- Level
- advanced
- Languages
- en → en
- Cards
- 32
- Markdown
- Antimicrobials, Oncology, Antidotes, Adverse Effects & Cytochrome P450 Interactions (.md)
Flashcards (32)
| # | Front (Term / Question) | Back (Definition / Answer) | Example | Multiple-Choice Options |
|---|---|---|---|---|
| 1 | How do Protamine Sulfate and Vitamin K1 / 4-Factor PCC differ in reversing Unfractionated Heparin versus Warfarin anticoagulation? | Unfractionated Heparin reversal: Protamine Sulfate is a strongly basic, positively charged polycationic peptide that binds stoichiometrically to strongly acidic, negatively charged heparin molecules, forming a stable inactive salt. Warfarin reversal: Intravenous Vitamin K1 (Phytonadione) stimulates de novo hepatic synthesis of functional clotting factors II, VII, IX, and X (takes 6-24 hours); immediate emergency reversal is achieved with 4-Factor Prothrombin Complex Concentrate (4F-PCC) containing active vitamin K-dependent factors. | ||
| 2 | What toxic metabolite produced by Cyclophosphamide causes hemorrhagic cystitis, and what uroprotective agent neutralizes it? | Cyclophosphamide (an alkylating mustard agent) is metabolized by hepatic CYP450 to 4-hydroxycyclophosphamide, which spontaneously breaks down into phosphoramide mustard (active alkylator) and Acrolein. Acrolein concentrates in the bladder and sloughs urothelium, producing sterile hemorrhagic cystitis. Preventive uroprotective agent: Mesna (sodium 2-mercaptoethanesulfonate), which binds and inactivates acrolein in the urinary tract, alongside vigorous IV hydration. | ||
| 3 | How do Polyene antifungals (Amphotericin B, Nystatin) and Azole antifungals (Fluconazole, Voriconazole) differ in their targeting of fungal ergosterol? | Polyenes (Amphotericin B, Nystatin) bind directly to pre-existing Ergosterol in the fungal cell membrane, forming transmembrane pore-like ion channels that leak intracellular K+ and Mg2+, killing the cell. Azoles inhibit the fungal cytochrome P450 enzyme 14-alpha-demethylase, blocking the conversion of Lanosterol to Ergosterol, impairing fungal cell membrane synthesis. | ||
| 4 | What is the molecular target of Imatinib (Gleevec), and for which hematologic malignancy is it targeted therapy? | A small-molecule competitive inhibitor of the ATP-binding pocket of the BCR-ABL receptor tyrosine kinase, created by the Philadelphia chromosome t(9;22)(q34;q11) reciprocal translocation. First-line targeted therapy for Chronic Myeloid Leukemia (CML); also inhibits c-KIT (CD117) tyrosine kinase in Gastrointestinal Stromal Tumors (GIST). | ||
| 5 | What is the mechanism of action of Linezolid, and what dangerous drug interaction can occur when combined with serotonergic medications? | Binds to the 23S ribosomal RNA of the 50S subunit, preventing formation of the functional 70S initiation complex; active against resistant Gram-positive pathogens (MRSA, VRE). Linezolid is a weak, reversible, non-selective Monoamine Oxidase Inhibitor (MAOI); co-administration with SSRIs, SNRIs, or other serotonergic drugs can precipitate life-threatening Serotonin Syndrome. | ||
| 6 | What classic pharmacokinetic drugs act as potent Cytochrome P450 Enzyme Inducers (CRAP GPS mnemonic)? | C: Carbamazepine; R: Rifampin; A: Alcohol (chronic); P: Phenytoin; G: Griseofulvin; P: Phenobarbital; S: St. John's Wort. Induction of CYP enzymes increases metabolic clearance of co-administered substrate drugs (e.g., oral contraceptives, warfarin, antiretrovirals), dramatically REDUCING their plasma concentrations and clinical efficacy. | ||
| 7 | What is the ribosomal target of Aminoglycosides (Gentamicin, Amikacin), and why are they clinically ineffective against obligate anaerobic bacteria? | Irreversibly bind the 30S ribosomal subunit, causing misreading of genetic code and inhibiting protein synthesis translocation. Transport across the bacterial inner cytoplasmic membrane requires an active, oxygen-dependent electron transport system; obligate anaerobes (e.g., Clostridium, Bacteroides) lack this oxygen-dependent uptake mechanism and are intrinsically resistant. Toxicities: Ototoxicity (vestibular/cochlear) and Nephrotoxicity (ATN). | ||
| 8 | What viral enzyme is required to activate Acyclovir, and what is the essential preventive measure against intravenous acyclovir nephrotoxicity? | Requires monophosphorylation by Herpesvirus-specific Thymidine Kinase (converting acyclovir to acyclovir monophosphate; host cellular kinases then convert it to acyclovir triphosphate, which inhibits viral DNA polymerase). Intravenous acyclovir can precipitate as insoluble needle-shaped crystals in renal collecting ducts, causing acute crystal nephropathy; this is prevented by aggressive IV volume hydration and slow drug infusion over 1-2 hours. | ||
| 9 | What classic pharmacokinetic drugs act as potent Cytochrome P450 Enzyme Inhibitors (SICKFACES.COM mnemonic)? | S: Sodium valproate; I: Isoniazid; C: Cimetidine; K: Ketoconazole; F: Fluconazole; A: Alcohol (acute intoxication); C: Chloramphenicol; E: Erythromycin / Clarithromycin; S: Sulfonamides; C: Ciprofloxacin; O: Omeprazole; M: Metronidazole; plus Grapefruit juice. CYP inhibition decreases substrate metabolism, leading to elevated drug blood levels and acute drug toxicity. | ||
| 10 | What culprit drugs cause Drug-Induced Lupus Erythematosus (DILE), and what autoantibody is positive in >95% of cases? | Classic culprit drugs (mnemonic: 'SHIPP'): Sulfasalazine, Hydralazine, Isoniazid, Procainamide, and Penicillamine (with Hydralazine and Procainamide having the highest incidence, especially in slow hepatic acetylators). Characterized by fever, arthralgias, and serositis. Greater than 95% of DILE cases test positive for Anti-Histone Antibodies, whereas Anti-dsDNA antibodies (hallmark of systemic lupus) are typically negative. | ||
| 11 | What bacterial enzymes do fluoroquinolones inhibit, and which ciprofloxacin risks appear in the US boxed warning? | Fluoroquinolones inhibit bacterial DNA gyrase and topoisomerase IV. Ciprofloxacin has boxed warnings for disabling and potentially irreversible tendon, peripheral-nerve and CNS effects, and exacerbation of myasthenia gravis. Aortic aneurysm/dissection and QT prolongation are additional warnings and precautions, not all part of the boxed warning. | ||
| 12 | What is the biochemical target of Echinocandin antifungals (Caspofungin, Micafungin), and what is their primary clinical role? | Non-competitively inhibit 1,3-beta-D-glucan synthase, blocking synthesis of beta-(1,3)-D-glucan, an essential structural polysaccharide in the fungal cell wall. Echinocandins (caspofungin, micafungin, anidulafungin) are first-line IV therapy for candidemia and invasive candidiasis, and salvage therapy for invasive aspergillosis, but have no clinically useful activity against Cryptococcus neoformans or Mucorales. | ||
| 13 | What is the enzymatic mechanism of 5-Fluorouracil (5-FU), and how does Leucovorin alter its pharmacodynamic activity differently than with methotrexate? | 5-FU is metabolized to 5-fluoro-2'-deoxyuridine monophosphate (5-FdUMP), which forms a stable covalent ternary complex with Thymidylate Synthase and 5,10-methylenetetrahydrofolate, irreversibly inhibiting dTMP synthesis ('thymineless cell death'). Unlike in methotrexate therapy where leucovorin acts as a rescue agent, in 5-FU therapy Leucovorin is administered to ENHANCE and potentiate 5-FU cytotoxicity by stabilizing the inhibitory ternary complex. | ||
| 14 | What is the molecular target of beta-lactam antibiotics, and how do beta-lactamase inhibitors overcome bacterial enzymatic resistance? | Beta-lactam antibiotics bind penicillin-binding proteins and inhibit peptidoglycan cross-linking. Beta-lactamase inhibitors protect a partner antibiotic against susceptible enzymes, but their mechanisms and spectra differ. Clavulanate, sulbactam, and tazobactam are mechanism-based inhibitors; avibactam forms a reversible covalent complex with susceptible serine beta-lactamases. They do not overcome every resistance mechanism. | ||
| 15 | How do macrolides and tetracyclines inhibit protein synthesis, and what is the important pediatric doxycycline exception? | Macrolides bind the bacterial 50S ribosomal subunit; tetracyclines bind the 30S subunit and prevent aminoacyl-tRNA attachment. Tooth and bone effects restrict some tetracycline uses in pregnancy and young children, but this is not an absolute class-wide ban. CDC recommends doxycycline for suspected Rocky Mountain spotted fever in patients of all ages, including children under 8. | ||
| 16 | What is the mechanism of action of Fomepizole in toxic alcohol (methanol and ethylene glycol) poisoning? | A potent competitive inhibitor of Alcohol Dehydrogenase (ADH). It prevents the metabolism of Ethylene Glycol into toxic glycolic and oxalic acids (which cause acute renal failure and calcium oxalate crystals) and Methanol into toxic formaldehyde and formic acid (which cause optic papillitis, retinal toxicity, and blindness). Ethanol can be used as an alternative competitive ADH substrate if fomepizole is unavailable. | ||
| 17 | What is the dose-limiting toxicity of Anthracyclines (Doxorubicin, Daunorubicin), and what iron-chelating cardioprotectant is utilized? | Dose-dependent dilated cardiomyopathy and congestive heart failure, mediated by the generation of iron-dependent free radicals (hydrogen peroxide and hydroxyl radicals) causing membrane lipid peroxidation and myofibrillar loss. The cardioprotective agent is Dexrazoxane, an intracellular iron-chelating agent that prevents free radical formation when high cumulative doses of doxorubicin are reached. | ||
| 18 | What specific chelating agents are indicated for Lead, Iron, and Copper toxicities? | Lead poisoning: Dimercaprol (BAL) + Calcium Disodium EDTA for severe toxicity; oral Succimer (DMSA) for pediatric outpatient chelation. Acute Iron poisoning: Deferoxamine (IV iron chelator; forms ferrioxamine complex producing 'vin rosé' reddish urine). Copper overload (Wilson's disease): Penicillamine or Trientine (chelators promoting urinary copper excretion) combined with oral Zinc (blocks intestinal copper absorption). | ||
| 19 | What are the hallmarks of Neuroleptic Malignant Syndrome (NMS) versus Malignant Hyperthermia, and how do their pharmacologic treatments differ? | NMS: caused by central Dopamine D2 receptor blockade (antipsychotics); characterized by 'lead-pipe' muscle rigidity, hyperthermia, autonomic instability, and extreme CK elevation; treated with Bromocriptine (dopamine agonist) and Dantrolene. Malignant Hyperthermia: triggered by volatile anesthetics and succinylcholine via uncontrolled skeletal muscle ryanodine receptor (RYR1) calcium release; treated immediately with IV Dantrolene (RYR1 inhibitor) and active cooling. | ||
| 20 | How do Vinca alkaloids (Vincristine, Vinblastine) and Taxanes (Paclitaxel) differ in their mechanisms of microtubule inhibition? | Vinca alkaloids (vincristine, vinblastine) bind beta-tubulin and INHIBIT tubulin polymerization into microtubules, preventing mitotic spindle formation and arresting cells in M phase (vincristine has dose-limiting peripheral/autonomic neurotoxicity and is fatal if given intrathecally; vinblastine causes dose-limiting myelosuppression). Taxanes (paclitaxel, docetaxel) bind polymerized beta-tubulin and PREVENT microtubule depolymerization, hyper-stabilizing microtubules so mitotic anaphase cannot proceed. | ||
| 21 | What are the molecular targets and clinical indications of Trastuzumab and Rituximab? | Trastuzumab: humanized monoclonal antibody targeting the extracellular domain of HER2 (ERBB2); indicated in HER2-positive breast and gastric cancers; causes reversible cardiotoxicity (reduced LVEF requiring baseline and serial echocardiography). Rituximab: chimeric anti-CD20 monoclonal antibody depleting B-lymphocytes in B-cell non-Hodgkin lymphomas, CLL, and autoimmune disorders; carries a boxed warning for fatal Hepatitis B virus (HBV) reactivation (requiring HBsAg and anti-HBc screening before initiation) and progressive multifocal leukoencephalopathy (PML). | ||
| 22 | What reverses dabigatran, and what changed in US availability of andexanet alfa for factor Xa inhibitors? | Idarucizumab binds dabigatran and is used for its urgent reversal in indicated situations. Andexanet alfa is a decoy factor Xa protein formerly marketed in the US for life-threatening or uncontrolled bleeding associated with apixaban or rivaroxaban. US commercial sales ended on December 22, 2025 after FDA safety concerns. Do not present it as a currently available US reversal option; follow current local emergency protocols. | ||
| 23 | What medications are high-risk culprits for Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), and what pharmacogenomic screening is recommended for Carbamazepine? | High-risk culprit drugs: Allopurinol (associated with HLA-B*58:01), Aromatic anticonvulsants (Carbamazepine, Lamotrigine, Phenytoin, Phenobarbital), Sulfonamide antimicrobials (TMP-SMX), Oxicam NSAIDs, and Nevirapine. Patients of Asian ancestry (especially Han Chinese, Thai, Malaysian, Filipino, and South Asian populations) must be screened for the HLA-B*15:02 allele before initiating Carbamazepine due to a markedly elevated risk of fatal SJS/TEN (similarly, HLA-B*57:01 screening is mandatory before starting Abacavir). | ||
| 24 | What are the clinical antidotes used in acute Carbon Monoxide poisoning and Cyanide poisoning? | Carbon monoxide poisoning: 100% normobaric oxygen via tight-fitting non-rebreather mask (shortens carboxyhemoglobin half-life from ~4–5 hours to ~60–90 minutes) or Hyperbaric Oxygen (HBO; shortens half-life to ~20–30 minutes in severe neurological/cardiac toxicity or pregnancy). Cyanide poisoning: IV Hydroxocobalamin (first-line; directly binds cyanide to form non-toxic cyanocobalamin excreted in urine) plus Sodium Thiosulfate (sulfur donor for rhodanese). Note: Nitrites (sodium/amyl nitrite, which induce methemoglobinemia to bind cyanide) are contraindicated in smoke-inhalation victims with concomitant carbon monoxide poisoning because methemoglobinemia further reduces oxygen-carrying capacity. | ||
| 25 | What is the mechanism of action of Vancomycin, and what is the pathophysiologic mechanism of 'Vancomycin Flushing Syndrome' (Red Man Syndrome)? | Vancomycin binds D-Ala-D-Ala termini of peptidoglycan precursors, inhibiting Gram-positive cell-wall synthesis. Vancomycin infusion reaction is usually rate-related, non-IgE-mediated histamine release. For the referenced IV product, infuse at no more than 10 mg/min and for at least 60 minutes, whichever requires longer. Stop and assess a suspected reaction; further management depends on severity and whether anaphylaxis is possible. | ||
| 26 | What is the specific pharmacologic antidote for toxic overdose of Beta-adrenergic blockers? | Intravenous Glucagon (activating myocardial glucagon Gs-coupled receptors to increase cAMP and contractility independently of beta-1 adrenoceptors) and High-Dose Insulin Euglycemia Therapy (HIET, e.g., regular insulin 1 unit/kg bolus + infusion with dextrose and potassium monitoring to improve myocardial inotropy and carbohydrate utilization), alongside atropine, IV calcium, and vasopressors. | ||
| 27 | What is the enzymatic target of Methotrexate, and what rescue agent is administered following high-dose methotrexate chemotherapy? | Competitively inhibits Dihydrofolate Reductase (DHFR), blocking conversion of dihydrofolate to tetrahydrofolate (THF), which depletes 1-carbon carriers needed for de novo purine synthesis and thymidylate (dTMP) synthesis. High-dose methotrexate rescue agent: Leucovorin (Folinic Acid / 5-formyl-THF), which bypasses DHFR to replenish intracellular folate pools in normal tissues. | ||
| 28 | What are the immune checkpoint targets of Pembrolizumab and Ipilimumab, and how are immune-related adverse events (irAEs) managed? | Pembrolizumab (and Nivolumab) blocks Programmed Cell Death Protein 1 (PD-1), and Ipilimumab blocks Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4). By blocking these inhibitory checkpoint receptors on T-cells, they restore antitumor T-cell cytotoxicity. Immune-related adverse events (autoimmune colitis, pneumonitis, hypophysitis, hepatitis, dermatitis) are managed by interrupting checkpoint therapy and initiating high-dose systemic Corticosteroids (e.g., Prednisone 1-2 mg/kg/day). | ||
| 29 | What is the clinical role of Cilastatin when formulated with Imipenem, and what central nervous system adverse effect is associated with carbapenems? | Imipenem is rapidly hydrolyzed and inactivated in the renal brush border by the brush-border enzyme Dehydropeptidase-I (producing nephrotoxic metabolites). Cilastatin is a competitive dehydropeptidase-I inhibitor that prevents renal degradation, maintaining high active imipenem urinary concentrations. Carbapenems (especially imipenem, particularly in patients with renal insufficiency or underlying brain lesions) lower the seizure threshold and can precipitate generalized Seizures. | ||
| 30 | Which antimicrobial agents provide reliable bactericidal coverage against Pseudomonas aeruginosa? | Antipseudomonal penicillins: Piperacillin-tazobactam. Cephalosporins: Cefepime (4th gen), Ceftazidime (3rd gen). Carbapenems: Meropenem, Imipenem-cilastatin, Doripenem (NOT Ertapenem!). Fluoroquinolones: Ciprofloxacin, Levofloxacin. Aminoglycosides: Amikacin, Tobramycin, Gentamicin. Monobactam: Aztreonam. Polymyxins: Colistin, Polymyxin B. | ||
| 31 | What is the molecular mechanism and dose-limiting organ toxicity of Cisplatin, and what chemoprotective scavenger is used? | Cisplatin is an inorganic platinum coordination complex that forms intra-strand and inter-strand cross-links at guanine N-7 positions in DNA, bending the helix and triggering apoptosis. Major dose-limiting toxicities: severe acute tubular necrosis (nephrotoxicity), high-frequency ototoxicity, and extreme emetogenicity. Chemoprotective agent: Amifostine (free radical scavenger) alongside aggressive chloride-containing isotonic saline hydration. | ||
| 32 | What happens to the International Normalized Ratio (INR) when a patient stabilized on Warfarin starts Co-trimoxazole (Bactrim) or Metronidazole? | Trimethoprim-sulfamethoxazole and metronidazole can increase warfarin exposure and INR, raising bleeding risk. Check INR more frequently when starting or stopping interacting antibiotics and individualize any dose adjustment. A fixed 30-50% dose reduction is not appropriate for every patient; infection, diet, baseline INR and other medicines also affect the response. |